CMS Declines to Offer Higher Payment Rate for BG Medicine's Galetin-3 Test Under New CPT Code | GenomeWeb

BG Medicine said this week that the Centers for Medicare and Medicaid Services have assigned a payment rate for the company's BGM Galectin-3 test under a new analyte-specific Current Procedural Terminology code that will go into effect Jan. 1, 2013.

The company added that CMS declined BG Medicine's request for a higher payment rate under this new code and will instead crosswalk the payment rate to the CPT code under which the test is currently paid.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.